Sequence Similarity Clusters for the Entities in PDB 1MFB

Entity #1 | Chains: L
IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 4 20579
95 % 2 39 537 Flexibility: Low
Max RMSD: 8.9, Avg RMSD: 2.4
PDBFlex
90 % 3 45 484
70 % 515 2593 1
50 % 1064 5263 1
40 % 1277 5933 1
30 % 1562 7388 1
Entity #2 | Chains: H
IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) protein, length: 219 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 4 20878
95 % 1 4 18869 Flexibility: No
Max RMSD: 0.5, Avg RMSD: 0.3
PDBFlex
90 % 2 11 4392
70 % 517 2550 2
50 % 1065 5263 1
40 % 1278 5933 1
30 % 1563 7388 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
3 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
4 5IVN 1 A BC2-nanobody 30538
5 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
6 5E7B 1 A nanobody nano-L06 9838
7 2P45 2 B ANTIBODY CAB-RN05 9838
8 2X1Q 1 A, B GELSOLIN NANOBODY 9844
9 5U64 1 B VHH-28 9838
10 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
11 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
12 4B41 1 A, B ANTIBODY G7 9844
13 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
14 4NZU 1 L 13PL heavy chain Fab 9606
15 4NZU 2 H 13PL light chain Fab 9606
16 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
17 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
18 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
19 5IMM 1 B Nanobody 9835
20 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
21 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
22 5NLU 1 A single domain llama antibody Nb36 9844
23 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
24 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
25 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 1MEX 1 L Fab 29G12 light chain 10090
27 1MEX 2 H Fab 29G12 heavy chain 10090
28 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
29 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
30 5IMK 1 B Nanobody 9835
31 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
32 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
33 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
34 6EH4 2 E Human T Cell Receptor Beta Chain 9606
35 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
36 4BUH 1 A, B CLONE M0418 SCFV 9606
37 4B50 1 A 2H10 LLAMA VHH 9844
38 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
39 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
40 6FR4 1 A TCR 003 alpha chain 9606
41 6FR4 2 B TCR 003 Beta Chain 9606
42 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
43 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
44 6DBA 1 A, B nanobody VHH R303 9838
45 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
46 6EH5 2 B Human T Cell Receptor Beta Chain 9606
47 5YD4 1 A, C, E, G scFv 4B08 10090
48 5YD3 1 A, C, E, G scFv 4B08 10090
49 2XT1 2 B CAMELID VHH 9 30538
50 5UD9 1 H Fab heavy chain 9606
51 5UD9 2 L Light chain 9606
52 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
53 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
54 4P48 1 A Antibody scFv 180 9031
55 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
56 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
57 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
58 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
59 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
60 6FR3 1 A 003 TCR Alpha Chain 9606
61 6FR3 2 B 003 TCR Beta Chain 9606
62 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
63 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
64 5J1S 3 C VHH domain BS-2 30538
65 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
66 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
67 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
68 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
69 5L6Q 1 A, B H5AL 9606
70 5J1T 3 C VHH domain BS-2 30538
71 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
72 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
73 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
74 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
75 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
76 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
77 4XCF 1 L 4E10 Fab light chain 9606
78 4XCF 2 H 4E10 Fab heavy chain 9606
79 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
80 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
81 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
82 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
83 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
84 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
85 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
86 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
87 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
88 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
89 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
90 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
91 5X08 1 H Fab 4E10 Heavy chain 9606
92 5X08 2 L Fab 4E10 Light chain 9606
93 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
94 2X1O 1 A, B GELSOLIN NANOBODY 9844
95 4QGY 1 A, B nanobody n25, VH domain 9844
96 5C2B 1 H scFv 3B4 heavy chain 9606
97 5C2B 2 L 3B4 light chain 9606
98 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
99 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
100 4XAW 1 L 4E10 Fab light chain 9606
101 4XAW 2 H 4E10 Fab heavy chain 9606
102 5VNV 1 A Nb.b201 32630
103 4P49 1 A Antibody scFv B8 9031
104 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
105 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
106 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
107 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
108 5DXW 1 A PD-L1 nanobody 10090
109 2NW2 1 A ELS4 TCR alpha chain 9606
110 2NW2 2 B ELS4 TCR beta chain 9606
111 5UCB 1 H Fab Heavy Chain 9606
112 5UCB 2 L Fab Light Chain 9606
113 3T0W 1 A, B immunoglobulin variable lambda domain 9606
114 2VXV 1 H HUMAN IGG ABT-325 9606
115 2VXV 2 L HUMAN IGG ABT-325 9606
116 4N9O 2 B Nanobody Nb484 Nb484 9844
117 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
118 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
119 3T0V 1 A immunoglobulin variable lambda domain 9606
120 4GXV 1 H, I Antibody 1F1, heavy chain 9606
121 4GXV 2 L, M Antibody 1F1, light chain 9606
122 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
123 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
124 2VXT 1 H MURINE IGG 125-2H 10090
125 2VXT 3 L MURINE IGG 125-2H 10090
126 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
127 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
128 1T2J 1 A M12-Variable Heavy domain 9606
129 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
130 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
131 6DBF 2 B InlB specific VHH R303 9838
132 6DBG 2 C, D VHH R303 9838
133 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
134 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
135 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
136 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
137 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
138 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
139 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
140 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
141 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
142 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
143 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
144 5W24 1 L 5C4 Fab Light Chain 10090
145 5W24 2 H 5C4 Fab Heavy Chain 10090
146 4HPY 1 H CH59 Fab heavy chain 9606
147 4HPY 2 L CH59 Fab light chain 9606
148 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
149 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
150 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
151 5VM6 1 A single domain camelid nanobody VHH T10 9844
152 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
153 4JG1 1 L Fab light chain 9606
154 4JG1 2 H Fab heavy chain 9606
155 1SQ2 2 N novel antigen receptor 7801
156 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
157 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
158 4KML 2 B Nanobody 9844
159 5VF2 1 A scFv 2D10 10090
160 5I8C 1 A VRC34.01 Fab heavy chain 9606
161 5I8C 2 B VRC34.01 Fab light chain 9606
162 4O5L 1 L Fab F045-092 light chain 9606
163 4O5L 2 H Fab F045-092 heavy chain 9606
164 5MYX 1 A, C Fab c#24 light chain 10090
165 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
166 4Z9K 2 B VHH2(F5) antibody 30538
167 3IFL 1 L 12A11 FAB antibody light chain 10090
168 3IFL 2 H 12A11 FAB antibody heavy chain 10090
169 5WK2 1 L M116 LIGHT CHAIN 9606
170 5WK2 2 H M116 HEAVY CHAIN FD 9606
171 3PP4 1 H GA101 Fab heavy chain 10090
172 3PP4 2 L GA101 Fab light chain 10090
173 3KDM 1 A, L Immunoglobulin light chain 9606
174 3KDM 2 B, H Immunoglobulin heavy chain 9606
175 5NIV 1 A Light chain of 5D3 Fab 10090
176 5NIV 2 B Heavy chain of 5D3 Fab 10090
177 5N4J 1 L LIGHT CHAIN 9606
178 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
179 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
180 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
181 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
182 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
183 5X4G 1 A 6H8 Fab heavy chain 10090
184 5X4G 2 B 6H8 Fab light chain 10090
185 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
186 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
187 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
188 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
189 4PTU 1 A Antibody pn132p2C05, light chain 9606
190 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
191 4TPR 1 L If kappa light chain 10090
192 4TPR 2 H Fab heavy chain 10090
193 5LMW 1 A Nanobody 9844
194 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
195 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
196 3IFN 1 H 12A11 FAB antibody heavy chain 10090
197 3IFN 2 L 12A11 FAB antibody light chain 10090
198 5U3P 1 H DH511.4 Fab Heavy Chain 9606
199 5U3P 2 L DH511.4 Fab Light Chain 9606
200 6BLA 1 H AMM01 Fab Heavy chain 9606
201 6BLA 2 L AMM01 Fab Light chain 9606
202 5NM0 1 A, B, C, D Nb36 9844
203 4TOY 1 H 35O22 Fab Heavy chain 9606
204 4TOY 2 L 35O22 Fab Light chain 9606
205 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
206 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
207 3NPS 2 B S4 FAB HEAVY CHAIN 9606
208 3NPS 3 C S4 FAB LIGHT CHAIN 9606
209 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
210 5I4F 1 A scFv 2D10 10090
211 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
212 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
213 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
214 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
215 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
216 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
217 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
218 5WN9 1 H scFv 2D10 9606
219 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
220 4XC3 1 L 4E10 Fab light chain 9606
221 4XC3 2 H 4E10 Fab heavy chain 9606
222 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
223 4PPT 1 A Engineered single domain VHH antibody 9844
224 3R0M 1 A, B Llama VHH A12 9844
225 4M5Y 1 H, I Fab 5J8 heavy chain 9606
226 4M5Y 2 L, M Fab 5J8 light chain 9606
227 4TQE 1 L If kappa light chain 10090
228 4TQE 2 H Fab heavy chain 10090
229 3ZKQ 2 D XA4813 9844
230 5YY4 1 A scFv 4B08 10090
231 4I13 2 B Protein ca1697 (nanobody) 9844
232 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
233 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
234 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
235 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
236 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
237 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
238 5C2U 1 B Nanobody Nanobody 9838
239 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
240 5VSI 2 L CH1/Ckappa Fab light chain 9606
241 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
242 1XFP 1 A heavy chain antibody VHH domain 9838
243 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
244 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
245 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
246 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
247 5JXA 1 H VRC03 Heavy chain 9606
248 5JXA 2 L VRC03 Light chain 9606
249 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
250 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
251 4POY 1 A VHH-metal 9844
252 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
253 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
254 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
255 5NLW 1 A nanobody Nb36 9844
256 3CDC 1 A, B Light Chain Amyloidogenic 9606
257 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
258 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
259 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
260 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
261 3NTC 1 L Fab light chain 10090
262 3NTC 2 H Fab heavy chain 10090
263 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
264 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
265 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
266 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
267 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
268 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
269 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
270 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
271 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
272 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
273 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
274 6BE3 1 H Fab (F598) Heavy Chain 9606
275 6BE3 2 L Fab (F598) Light Chain 9606
276 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
277 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
278 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
279 3G9A 2 B Minimizer 9838
280 4NWU 1 H APE1551 Ab Fab heavy chain 9606
281 4NWU 2 L APE1551 Ab Fab light chain 9606
282 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
283 1KGC 1 D T-cell receptor alpha chain 9606
284 1KGC 2 E T-cell receptor beta chain 9606
285 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
286 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
287 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
288 6FRC 2 B Human T-Cell Receptor beta Chain 9606
289 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
290 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
291 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
292 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
293 5EWI 1 H VRC38.01 Heavy Chain 9606
294 5EWI 2 L VRC38.01 Light Chain 9606
295 5E2W 1 L AT8 LIGHT CHAIN 10090
296 5E2W 2 H AT8 HEAVY CHAIN 10090
297 5MYK 1 A Fab c#17 light chain 10090
298 5MYK 2 B Fab c#17 heavy chain 10090
299 6FUQ 1 A Human F11 T-Cell Receptor 9606
300 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
301 4NZR 1 H PGT135 heavy chain Fab 9606
302 4NZR 2 L PGT135 light chain Fab 9606
303 5MYO 1 A, C Fab c#6 light chain 10090
304 5MYO 2 B, D Fab c#6 heavy chain 10090
305 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
306 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
307 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
308 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
309 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
310 5UEL 1 H 354NC102 Fab Heavy Chain 9606
311 5UEL 2 L 354NC102 Fab Light Chain 9606
312 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
313 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
314 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
315 2P43 2 B ANTIBODY CAB-RN05 9838
316 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
317 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
318 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
319 5E2V 1 L AT8 LIGHT CHAIN 10090
320 5E2V 2 H AT8 HEAVY CHAIN 10090
321 4KRN 1 A Nanobody/VHH domain EgA1 9844
322 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
323 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
324 4GFT 2 B Nanobody 9844
325 4TVS 2 a, b VHH Domain BS-1 30538
326 4W6Y 2 B Nanobody NbFedF9 9844
327 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
328 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
329 6EZW 1 B VHH antibody BCD090-M2 9844
330 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
331 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
332 5JUE 1 L light chain of UIC2 Fab 10090
333 5JUE 2 H heavy chain of UIC2 Fab 10090
334 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
335 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
336 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
337 1UAC 2 H Ig VH,anti-lysozyme 10090
338 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
339 5JR1 1 H 10E8 heavy chain 9606
340 5JR1 2 L 10E8 mature light chain 9606
341 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
342 6CA7 1 L PCT64_13C light chain 9606
343 6CA7 2 H PCT64_13C heavy chain 9606
344 5VF6 1 A single chain variable fragment 9031
345 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
346 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
347 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
348 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
349 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
350 6FR9 2 B T-Cell Receptor F11 beta chain 9606
351 5OB5 2 H fAb Heavy chain 9606
352 5OB5 3 L fAb Light chain 9606
353 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
354 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
355 5I66 1 A 8B6 antibody, heavy chain 10090
356 5I66 2 B 8B6 antibody, light chain 10090
357 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
358 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
359 6BZY 1 H 22D11 Heavy Chain 10090
360 6BZY 2 L 22D11 Light Chain 10090
361 3QQ9 1 C, L 101F LIGHT CHAIN 10090
362 3QQ9 2 D, H 101F HEAVY CHAIN 10090
363 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
364 5TKK 3 L mouse antibody vFP5.01 light chain 10090
365 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
366 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
367 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
368 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
369 5W6C 1 H UCA Fab heavy chain 9606
370 5W6C 2 L UCA Fab light chain 9606
371 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
372 5I1K 1 L FAB LIGHT CHAIN 9606
373 5I1K 2 H FAB HEAVY CHAIN 9606
374 3OZ9 1 L Fab NC-1 kappa light chain 10090
375 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
376 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
377 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
378 5V7U 1 L CBTAU-22.1 Fab light chain 9606
379 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
380 5UEA 1 A, H Fab Heavy Chain 9606
381 5UEA 3 B, L Fab Light Chain 9606
382 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
383 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
384 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
385 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
386 3G5Y 1 A 175 light chain 10090
387 3G5Y 2 B 175 heavy chain 10090
388 5O02 2 C Nanobody (VHH) Nano-4 30538
389 5NMV 1 L Fab light chain 10088
390 5NMV 2 H Fab heavy chain 10088
391 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
392 4N8C 2 L, M Light chain of monoclonal antibody 10090
393 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
394 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
395 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
396 4HGW 1 A Antibody Fab fragment, light chain 10090
397 4HGW 2 B Antibody Fab fragment, heavy chain 10090
398 1NLB 1 L antibody 19D9D6 light chain 10090
399 1NLB 2 H antibody 19D9D6 heavy chain 10090
400 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
401 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
402 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
403 3VFG 1 L 3F8 Light Chain 10090
404 3VFG 2 H 3F8 Heavy Chain 10090
405 4X7F 2 C, D Nano-25 Nanobody 30538
406 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
407 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
408 3QRG 1 L Fab light chain 9606
409 3QRG 2 H Fab heavy chain Fd fragment 9606
410 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
411 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
412 5M6A 1 A, B, C, D Bence-Jones light chain 9606
413 4LLY 2 B, D light chain Clambda 9606
414 4LGR 2 B Camelid nanobody (VHH3) 30538
415 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
416 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
417 5EZI 1 H Fab c12 heavy chain 9606
418 5EZI 2 L Fab c12 Light chain 9606
419 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
420 4K23 1 H anti-uPAR antibody, heavy chain 10090
421 4K23 2 L anti-uPAR antibody, light chain 10090
422 5J57 2 B VHH single chain antibody V5E1 30538
423 3NCJ 1 L Fab15 Mut8 light chain 9606
424 3NCJ 2 H Fab15 Mut8 heavy chain 9606
425 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
426 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
427 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
428 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
429 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
430 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
431 5W05 1 L M59 FAB LIGHT CHAIN 10090
432 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
433 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
434 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
435 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
436 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
437 5OMM 2 C Nanobody (VHH) Nano-14 30538
438 5E03 1 A mouse CTLA-4 nanobody 10090
439 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
440 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
441 4M61 1 A, C Fab A52 light chain 10090
442 4M61 2 B, D Fab A52 heavy chain 10090
443 5LZ0 1 A, B PorM nanobody 9844
444 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
445 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
446 1UM5 1 L Antibody 21H3 L chain 10090
447 1UM5 2 H Antibody 21H3 H chain 10090
448 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
449 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
450 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
451 4NWT 1 L APE1531 Ab Fab light chain 9606
452 4NWT 2 H APE1531 Ab Fab heavy chain 9606
453 6DBE 1 A, B nanobody VHH R303 9844
454 3WHX 1 A mAb Fab H fragment 10090
455 3WHX 2 B mAb Fab L fragment 10090
456 3NA9 1 L Fab15 light chain 9606
457 3NA9 2 H Fab15 heavy chain 9606
458 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
459 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
460 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
461 6FUO 2 B Human F11 T-Cell Receptor 9606
462 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
463 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
464 4LRI 1 A, B MSL-109 Light Chain 9606
465 4LRI 2 C, P MSL-109 Heavy Chain 9606
466 2XXC 1 B CAMELID VHH 9 30538
467 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
468 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
469 4JN2 1 A, L anti dabigatran Fab 10090
470 4JN2 2 B, H anti dabigatran Fab 10090
471 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
472 4XBE 2 H 4E10 Fab heavy chain 9606
473 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
474 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
475 6BE2 1 H Fab (F598) Heavy Chain 9606
476 6BE2 2 L Fab (F598) Light Chain 9606
477 3QYC 1 A, B VH domain of IgG molecule 9606
478 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
479 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
480 4JFZ 1 L Fab light chain 9606
481 4JFZ 2 H Fab heavy chain 9606
482 5VAK 2 B Nb914 Nanobody 9844
483 3WIF 1 A mAb Fab H fragment 10090
484 3WIF 2 B mAb Fab L fragment 10090
485 5U6A 1 A Light Chain 9606
486 5U6A 2 B Heavy Chain 9606
487 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
488 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
489 3MBX 1 L X836 LIGHT CHAIN 10090
490 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
491 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
492 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
493 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
494 2XXM 2 B CAMELID VHH 9 30538
495 6APC 1 H Epididymis luminal protein 214 9606
496 6APC 2 L IGL@ protein 9606
497 6BJ8 3 D TCR 55 alpha chain 9606
498 6BJ8 4 H TCR 55 beta chain 9606
499 5IR3 1 A Ig lambda chain V-VI region AR 9606
500 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
501 4HHA 1 A Fab KE5 Fab fragment KE5 9606
502 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
503 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
504 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
505 4RGO 2 H 14G8 heavy chain Fab 10090
506 4RGO 3 L 14G8 light chain Fab 10090
507 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
508 5GRY 1 A, G diabody 9606
509 5UEK 2 H Fab 12E Heavy Chain 9606
510 5UEK 3 L Fab 12E Light Chain 9606
511 3NAA 1 L Fab15 Mut5 light chain 9606
512 3NAA 2 H Fab15 Mut5 heavy chain 9606
513 6DBD 1 A, B, C, D nanobody VHH R326 9844
514 1Q0X 1 L Fab 9B1, light chain 10090
515 1Q0X 2 H Fab 9B1, heavy chain 10090
516 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
517 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
518 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
519 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
520 5JDS 1 B Nanobody 9835
521 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
522 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
523 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
524 5IK3 2 B, D 1E03 Fab fragment light chain 9606
525 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
526 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
527 5XLI 1 a, b FabL 10090
528 5XLI 2 c, d FabH 10090
529 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
530 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
531 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
532 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
533 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
534 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
535 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
536 4WUK 1 H CH65 heavy chain 9606
537 4WUK 2 L CH65 light chain 9606
538 5L8L 2 B New antigen receptor variable domain 168098
539 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
540 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
541 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
542 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
543 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
544 5JOP 1 D, L Fab 14.22 light chain 10090
545 5JOP 2 E, H Fab14.22 heavy chain 10090
546 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
547 4HPO 1 H CH58 Fab heavy chain 9606
548 4HPO 2 L CH58 Fab light chain 9606
549 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
550 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
551 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
552 5UKN 2 L DH522UCA Fab fragment light chain 9544
553 4AIZ 1 A, C, D V2-17 PROTEIN 9606
554 4AIZ 2 B V2-17 PROTEIN 9606
555 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
556 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
557 5L21 2 B VHH-C2 30538
558 5IT2 1 H heavy chain 9606
559 5IT2 2 L light chain 9606
560 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
561 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
562 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
563 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
564 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
565 2W59 1 A, B IGY FCU3-4 9031
566 5FWO 1 A NANOBODY 9844
567 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
568 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
569 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
570 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
571 4L1H 1 A Ig kappa chain V-I region Rei 9606
572 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
573 5MO3 3 L Fab of monoclonal antibody, light chain 10090
574 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
575 5GZ0 1 A, C FM329 light chain 1383439
576 5GZ0 2 B, D FM329 heavy chain 1383439
577 3B9V 1 A, B, C, D heavy chain variable domain 9606
578 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
579 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
580 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
581 6BQB 1 L MGG4 Fab light chain 9606
582 6BQB 2 H MGG4 Fab heavy chain 9606
583 4PUB 1 H DX-2930 HEAVY CHAIN 9606
584 4PUB 2 L DX-2930 LIGHT CHAIN 9606
585 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
586 6B14 2 L Light chain of Fab BL3-6S97N 10090
587 5N88 1 A, H VH59 antibody 9606
588 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
589 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
590 5TEZ 4 I TCR F50 alpha chain 9606
591 5TEZ 5 J TCR F50 beta chain 9606
592 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
593 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
594 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
595 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
596 5GS3 1 A, H diabody protein 9606
597 3BD3 1 A, B catalytic antibody 10090
598 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
599 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
600 2OTU 1 A, C, E, G Fv light chain variable domain 10090
601 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
602 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
603 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
604 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
605 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
606 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
607 5VKD 2 H Fab Heavy Chain 9606
608 5VKD 3 L Fab light chain 9606
609 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
610 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
611 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
612 5XHG 1 A, C polypeptide(L) 562
613 5XHG 2 B, D polypeptide(H) 562
614 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
615 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
616 5L8J 2 B New antigen receptor variable domain 168098
617 3UYR 1 H antibody Fab heavy chain 10090
618 3UYR 2 L antibody Fab light chain 10090
619 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
620 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
621 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
622 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
623 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
624 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
625 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
626 3OAZ 2 K, L Fab 2G12, light chain 9606
627 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
628 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
629 1T6V 2 N, O novel antigen receptor 7801
630 1ZAN 1 L Fab AD11 Light Chain 10116
631 1ZAN 2 H Fab AD11 Heavy Chain 10116
632 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
633 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
634 6CJK 1 A, C Immunoglobulin Fab light chain 9986
635 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
636 4N0Y 1 H IGH526 Heavy Chain 9606
637 4N0Y 2 L IGH526 Light Chain 9606
638 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
639 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
640 5MTH 1 A, H antibody Fab heavy chain 10090
641 5MTH 2 B, L antibody Fab light chain 10090
642 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
643 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
644 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
645 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
646 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
647 1RZF 1 L Fab E51 light chain 9606
648 1RZF 2 H Fab E51 heavy chain 9606
649 4N1C 1 A, B immunoglobulin variable light chain domain 9606
650 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
651 4KTE 2 L GE148 Light Chain Fab 9544
652 5I8O 1 H HMM5 antibody heavy chain 9606
653 5I8O 2 L HMM5 antibody light chain 9606
654 4OUO 1 A anti Bla g 1 scFv 9031
655 4JG0 1 L Fab light chain 9606
656 4JG0 2 H Fab heavy chain 9606
657 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
658 4YGV 2 B, L aDabi-Fab2a light chain 9606
659 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
660 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
661 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
662 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
663 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
664 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
665 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
666 3EO0 1 A, C GC-1008 Fab Light Chain 10090
667 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
668 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
669 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
670 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
671 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
672 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
673 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
674 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
675 6FUR 2 B, D Human F11 T-Cell Receptor 9606
676 4POU 2 B VHH Antibody 9844
677 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
678 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
679 4FQI 3 H antibody CR9114 heavy chain Fab 9606
680 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
681 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
682 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
683 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
684 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
685 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
686 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
687 4JHA 2 L D25 light chain 9606
688 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
689 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
690 4PTT 1 A Antibody pn132p2C05, light chain 9606
691 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
692 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
693 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
694 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
695 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
696 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
697 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
698 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
699 2P42 2 B, D ANTIBODY CAB-RN05 9838
700 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
701 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
702 6CPH 1 D TCR alpha chain 9606
703 6CPH 2 E TCR beta chain 9606
704 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
705 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
706 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
707 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
708 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
709 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
710 4DGV 1 H HCV1 Heavy Chain Fab 9606
711 4DGV 2 L HCV1 Light Chain 9606
712 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
713 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
714 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
715 5TH2 1 A, C cetuximab Fab, light chain 10090
716 5TH2 2 B, D cetuximab Fab, heavy chain 10090
717 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
718 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
719 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
720 5I8K 1 L HHH1 Fab Light chain 9606
721 5I8K 2 H HHH1 Fab Heavy chain 9606
722 4QLR 1 A, B Llama nanobody n02 VH domain 9844
723 5J56 2 B VHH single chain antibody V1C7 30538
724 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
725 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
726 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
727 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
728 1YNL 1 L Ig gamma light chain 10090
729 1YNL 2 H Ig gamma heavy chain 10090
730 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
731 5EPM 2 B, F Antibody Fab fragment light chain 10090
732 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
733 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
734 5VH5 1 A Infliximab Fc 10090
735 3UMT 1 A scFv heavy chain and light chain 10090
736 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
737 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
738 4NUJ 1 A PGT152 light chain 9606
739 4NUJ 2 B PGT152 heavy chain 9606
740 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
741 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
742 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
743 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
744 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
745 3U2S 2 B, L PG9 light chain 9606
746 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
747 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
748 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
749 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
750 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
751 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
752 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
753 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
754 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
755 4NUG 1 L PGT151 light chain 9606
756 4NUG 2 H PGT151 heavy chain 9606
757 3IU4 1 H chP3 Fab heavy chain 10090
758 3IU4 2 L chP3 Fab light chain 10090
759 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
760 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
761 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
762 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
763 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
764 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
765 1P7K 1 A, L antibody light chain FAB 10090
766 1P7K 2 B, H antibody heavy chain FAB 10090
767 4NBX 2 B A20.1 VHH 9844
768 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
769 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
770 3RVV 2 C 4C1 - light chain 10090
771 3RVV 3 D 4C1 - heavy chain 10090
772 4HEP 2 G vHH17 domain 9844
773 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
774 3P0Y 2 H Fab DL11 heavy chain 9606
775 3P0Y 3 L Fab DL11 light chain 9606
776 4NPY 1 A, L germline PGT121 light chain Fab 9606
777 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
778 6ANA 2 H LL2 Fab Heavy Chain 10090
779 6ANA 3 L LL2 Fab Light Chain 10090
780 5IBU 1 B, L 6652 Light Chain 9606
781 5IBU 2 G, H 6652 Heavy Chain 9606
782 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
783 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
784 5VPL 2 C 4C1 - LIGHT CHAIN 10090
785 5VPL 3 D 4C1 - HEAVY CHAIN 10090
786 6AOD 1 A FXIa Antibody FAB Light Chain 9606
787 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
788 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
789 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
790 2YPV 2 H FAB 12C1 10090
791 2YPV 3 L FAB 12C1 10090
792 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
793 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
794 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
795 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
796 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
797 4JY5 1 L PGT122 light chain Fab 9606
798 4JY5 2 H PGT122 heavy chain Fab 9606
799 6ELE 1 A, H fAB heavy chain 9606
800 6ELE 2 B, L fAB light chain 9606
801 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
802 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
803 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
804 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
805 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
806 6B5R 1 H CIS42 Fab Heavy chain 9606
807 6B5R 2 L CIS42 Fab Light chain 9606
808 5IML 2 B Nanobody 9835
809 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606 1.1.1 | Details
810 3NAC 1 L Fab15 Mut7 light chain 9606
811 3NAC 2 H Fab15 Mut7 heavy chain 9606
812 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
813 3A6C 2 H IG VH, anti-lysozyme 10090
814 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
815 2DQD 2 H Ig VH,anti-lysozyme 10090
816 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
817 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
818 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
819 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
820 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
821 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
822 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
823 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
824 1Q72 1 L Fab M82G2, Light chain 10090
825 1Q72 2 H Fab M82G2, Heavy chain 10090
826 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
827 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
828 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
829 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
830 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
831 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
832 4YHO 1 H aDabi-Fab3 heavy chain 9606
833 4YHO 2 L aDabi-Fab3 light chain 9606
834 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
835 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
836 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
837 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
838 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
839 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
840 4DGY 1 H HCV1 Heavy Chain Fab 9606
841 4DGY 2 L HCV1 Light Chain 9606
842 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
843 3A67 2 H IG VH, anti-lysozyme 10090
844 2APB 1 A T-cell receptor beta chain V 10116
845 2APX 1 A T cell receptor beta chain V 10116
846 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
847 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
848 6EH6 2 B Human T Cell Receptor BetaChain 9606
849 5EN2 1 A GD01 heavy chain 10090
850 5EN2 2 B GD01 light chain 10090
851 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
852 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
853 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
854 1J1X 2 H Ig VH,anti-lysozyme 10090
855 5L8K 2 B New antigen receptor variable domain 168098
856 5M2J 2 D Anti-(ED-B) scFV 9606
857 3MXW 2 L 5E1 light chain 9606
858 3MXW 3 H 5E1 heavy chain 9606
859 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
860 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
861 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
862 2DQC 2 H Ig VH,anti-lysozyme 10090
863 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
864 1J1O 2 H Ig VH,anti-lysozyme 10090
865 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
866 3EO9 1 L Efalizumab Fab fragment, light chain 9606
867 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
868 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
869 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
870 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
871 4M62 2 H, I GEP2 FV heavy chain 9606
872 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
873 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
874 5IVO 1 A BC2-nanobody 30538
875 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
876 1J1P 2 H Ig VH,anti-lysozyme 10090
877 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
878 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
879 4NBZ 2 B, D A26.8 VHH 9844
880 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
881 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
882 5WUV 1 L light chain 9606
883 5WUV 2 H heavy chain 9606
884 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
885 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
886 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
887 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
888 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
889 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
890 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
891 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
892 5AYU 2 H Ig VH,anti-lysozyme 10090
893 4JM4 1 H PGT 135 Heavy Chain Fab 9606
894 4JM4 2 L PGT 135 Light Chain Fab 9606
895 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
896 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
897 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
898 3A6B 2 H IG VH, anti-lysozyme 10090
899 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
900 2DQJ 2 H Ig VH,anti-lysozyme 10090
901 5F21 2 B nanobody MU375 9844
902 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
903 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
904 6B0G 1 C 1245 Antibody, Light Chain 9606
905 6B0G 2 D 1245 Antibody, Heavy Chain 9606
906 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
907 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
908 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
909 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
910 4WNQ 1 A, C TCR Variable Delta 1 chain and TCR constant Alpha chain 9606
911 4WNQ 2 B, D TCR Variable Beta 2 (TRBV20) chain and TCR constant Beta chain 9606
912 6D0X 1 A 2140 Antibody, heavy chain 9606
913 6D0X 2 B 1210 Antibody, light chain 9606
914 2Q86 1 A, C Valpha14 TCR extracellular domain 10090
915 2Q86 2 B, D Vbeta8.2 extracellular domain 10090
916 2P44 2 B ANTIBODY CAB-RN05 9838
917 6BE4 1 H Fab (F598) Heavy Chain 9606
918 6BE4 2 L Fab(F598) Light Chain 9606
919 6FRB 1 A Human T-Cell Receptor F11 alpha chain 9606
920 6FRB 2 B Human T-Cell Receptor F11 beta Chain 9606
921 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
922 5TPP 1 L DH270.5 Fab heavy chain 9606
923 5TPP 2 H DH270.5 Fab light chain 9606
924 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
925 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
926 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
927 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
928 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
929 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
930 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
931 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
932 5TP3 1 A, B F-VHH-4 9844
933 5D7K 1 D MAV36 TCR Alpha Chain 9606
934 5D7K 2 E MAV36 TCR Beta Chain 9606
935 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
936 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
937 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody